Integrin a4/b7 is a homing molecule which facilitates the adhesion of leukocytes to the endothelium of the blood vessels of the gut, through binding with MadCAM1, and is the target of monoclonal antibody therapies for IBD, such as vedalizumab. The gene discussed is MADCAM1; the disease is inflammatory bowel disease.